1-6 of 6
Bertrand Joly, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

Olivier Casasnovas, MD, Judith Racape, MD, Julie Dechene, Reda Bouabdallah, MD, Pauline Brice, MD, Julien Lazarovici, MD, Hervé Ghesquieres, MD PhD, Aspasia Stamatoulas Bastard, MD, Jehan Dupuis, MD, Anne-Claire Gac, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Pierre Feugier, MD, Franck Morschhauser, MD PhD, Marc André, MD, Alina Berriolo-Riedinger, MD, Veronique Edeline, MD, Clémentine Joubert, PhD, Michel Meignan, MD, Isabelle Demeestere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136056
Published: 2020
Journal Articles

Treatment of Myeloma Cast Nephropathy (MCN): A Randomized Trial Comparing Intensive Haemodialysis (HD) with High Cut-Off (HCO) or Standard High-Flux Dialyzer in Patients Receiving a Bortezomib-Based Regimen (the MYRE Study, by the Intergroupe Francophone du Myélome (IFM) and the French Society of Nephrology (SFNDT))

Frank Bridoux, MD PhD, Brigitte Pegourie, MD, Karine Augeul-Meunier, MD, Bruno Royer, MD, Bertrand Joly, MD, Thierry Lamy, MD PhD, Brigitte Kolb, Lofti Benboubker, Bertrand Arnulf, MD, Arnaud Jaccard, MD PhD, Sylvie Chevret, Jean-Paul Fermand, MD
Journal: Blood
Blood (2016) 128 (22): 978.
https://doi.org/10.1182/blood.V128.22.978.978
Published: 2016
Journal Articles

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

Olivier Casasnovas, MD, Pauline Brice, MD, Reda Bouabdallah, MD, Gilles A. Salles, MD PhD, Aspasia Stamatoullas, MD, Jehan Dupuis, MD, Oumedaly Reman, MD, Thomas Gastinne, MD, Bertrand Joly, MD, Krimo Bouabdallah, MD, Emmanuelle Nicolas-Virelizier, MD, Serge Bologna, MD, Franck Morschhauser, MD, Richard Delarue, MD, Hassan Farhat, MD, Philippe Quittet, MD, Alina Berriolo-Riedinger, MD, Adrian Tempescul, Véronique Edeline, MD, Herve Maisonneuve, MD, Jean Claude Eisenmann, MD, Alexandra Traverse-Glehen, Marc Andre, MD, Nicolas Mounier, MD PhD, Michel Meignan, MD PhD, Christophe Fermé, MD
Journal: Blood
Blood (2015) 126 (23): 577.
https://doi.org/10.1182/blood.V126.23.577.577
Published: 2015
Journal Articles

Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter Study

Emilie Reboursiere, Fabien Le Bras, Franck Morschhauser, MD, Emmanuel Gyan, MD PhD, Aline Clavert, MD, Sandra Malak, David Sibon, MD, Marion Damge, Claude Gardin, Luc-Matthieu Fornecker, Reda Garidi, Sabine Tricot, Roch Houot, Bertrand Joly, MD, Wajed Abarah, MD, Bachra Choufi, MD, Anne-dominique Pham, Sylvain P Chantepie, MD, Christophe Fruchart, MD, Anne-Claire Gac, Catherine Ollivier, Emilie Marin, Violaine Safar, Anne Parcelier, MD, Herve Maisonneuve, MD, Emmanuel Bachy, Guillaume Cartron, MD PhD, Arnaud Jaccard, MD PhD, Olivier Tournilhac, Cedric Rossi, MD, Aurore Perrot, Jean-Alain Martignoles, Herve Tilly, MD PhD, Gandhi Damaj, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1505.
https://doi.org/10.1182/blood.V126.23.1505.1505
Published: 2015
Journal Articles

Frontline Therapy with the Ribvd Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final Results of a Prospective Phase II Trial By the Lysa Group

Remy Gressin, MD, Mary Callanan, MD PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Marie Pierre Moles, MD, Guillaume Cartron, MD, Roch Houot, MD PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD PhD, Anne Banos, MD, Christiane Mounier, MD, Jehan Dupuis, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD PhD, Lionel Karlin, Pierre Feugier, MD PhD, Luc Matthieu Fornecker, MD, Cecile Chabrot, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Katell Le Dû, Nadine Morineau, Hacene Zerazhi, MD, Jean Fontan, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MDPhD, Steven Le Gouill, MD PhD, Ghandi Damaj, MD
Journal: Blood
Blood (2014) 124 (21): 148.
https://doi.org/10.1182/blood.V124.21.148.148
Published: 2014
Journal Articles

The Ribvd Regimen (Rituximab IV, Bendamustine IV, Velcade SC, Dexamethasone IV) Offers a High Complete Response Rate In Elderly Patients With Untreated Mantle Cell Lymphoma. Preliminary Results Of The Lysa Trial “Lymphome Du Manteau 2010 SA”

Remy Gressin, MD, Mary Callanan, MD, PhD, Nicolas Daguindau, MD, Adrian Tempescul, MD, Sylvain Carras, Guillaume Cartron, MD, PhD, Anne Schmitt, MD, Roch Houot, MD, PhD, Caroline Dartigeas, MD, Jean Michel Pignon, MD, Selim Corm, MD, PhD, Anne Banos, MD, Jehan Dupuis, MD, Christiane Mounier, MD, Margareth Macro, MD, Joel Fleury, MD, Fabrice Jardin, MD, PhD, Lionel Kardin, MD, Gandhi Damaj, MD, Pierre Feugier, MD, PhD, luc Matthieu Fornacker, MD, Cecile molucon Chabrot, MD, Veronique Dorvaux, MD, Krimo Bouabdallah, MD, Sandy Amorin, MD, Reda Garidi, MD, Laurent Voillat, MD, Bertrand Joly, MD, Philippe Solal-Céligny, MD, Nadine Morineau, MD, Marie Pierre Moles, MD, Hacene Zerazhi, MD, Jean Fontan, MD, Yazid Arkam, MD, Magda Alexis, MD, Vincent Delwail, MD, Jean Pierre Vilque, MD, Loic Ysebaert, MD PhD, Steven Le Gouill, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 370.
https://doi.org/10.1182/blood.V122.21.370.370
Published: 2013